US equities |
SPCX $158.44 ▲+7.21% MU $918.06 ▲+2.45% NVDA $221.76 ▲+2.44% TSLA $387.20 ▲+3.61% META $708.16 ▲+2.00% SNDK $1,388.32 ▲+1.68% GOOGL $335.03 ▼-1.54% AMD $553.56 ▲+3.52%
FinancialContent

Latest News about Jayson Bedford

Recent news which mentions Jayson Bedford

Johnson & Johnson's MedTech Momentum Expected To Rebound In 2025 Despite Current Hurdles: Analyst
Tickers JNJ NEWS
Tags Jayson Bedford BofA Securities Analyst Color
From Benzinga
Tandem Diabetes Pressured As Control-IQ Trials Combined; Raymond James Downgrades TNDM
Tickers MDT TNDM
Tags Jayson Bedford TNDM Expert Ideas
From Benzinga
4 Analysts Takeaways From Johnson & Johnson's Quarterly Results: What Investors Need To Know
Tickers JNJ
Tags Larry Biegelsen Benzinga Price Target
From Benzinga